Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
Today’s growing biologics challenges make the choice of a CDMO critical. You need a trusted and experienced partner from DNA sequence to commercial launch and at each checkpoint along the way.